Search
Filter
-
News ArticleClimate Risks Create More Exposure for Directors and Officers, Insurers
-
News ArticleNew Legal Protections for CEOS Pop Up on Proxies
-
SPAC Current Events Roundup: SPARCs, Settlements, and LiquidationsTo celebrate the two-year anniversary of the SPAC Notebook, we’ve curated a list of recent SPAC developments that are worth keeping an eye on.View Insight
-
Commercial Insurance 101: General Liability & Auto
Watch two casualty specialists for an interactive discussion on primary general liability and auto liability basics including program structures, coverages, exclusions and claims examples. We’ll also touch on utilizing umbrella/excess liability for additional limit over these core liability coverages.
-
What’s Driving Benefits Renewal Hikes and How Can You Prepare?
This article will discuss the factors driving the premium increases and provide steps employers can take now to prepare for the changes ahead.
-
News ArticleWoodruff Sawyer Releases 2023 D&O Preview
-
Looking Ahead to 2024: Trends in M&A and Private Equity — Webinar
As expected, 2023 has proven to be a tough year for dealmakers. We'll discuss how this has impacted M&A insurance and due diligence and go over our predictions for 2024.
-
What Is a Purpose Trust?
Learn about what a purpose trust is and how you can protect it.
-
News ArticleInsider Hedging - Just Ban Them Both
-
News ArticlePopular Reads on JD Supra
-
News ArticleWar Exclusions Gains Traction in Cyber Market
-
What Are Key Exposures of Pre-Human Clinical Trial-Stage Companies?
In part one of our Risk Management for Your Life Sciences Company series, we break down the unique exposures companies face during the Research & Development: Pre-Human Clinical Trials stage.